TABLE 5.
Highlighted patents relating to diet, gut microbiome, and human health.
| Patent number | Name | Owner | Year |
| US20100172874A1 | Gut microbiome as a biomarker and therapeutic target for treating obesity or an obesity-related disorder | Washington University in St. Louis | 06 |
| WO2007136553A2 | Bacterial strains, compositions including same and probiotic use thereof | Benson et al. | 06 |
| US20110123501A1 | Gut flora and weight management | Nestec S.A. | 07 |
| EP2178543B1 | Lactobacillus rhamnosus and weight control | Nestec S.A. | 07 |
| US9371510B2 | Probiotic compositions and methods for inducing and supporting weight loss | Brenda E. Moore | 07 |
| US9113641B2 | Probiotic bacteria and regulation of fat storage | Arla Foods amba | 07 |
| EP2296489A1 | Lactobacillus paracasei and weight control | Nestec S.A. | 08 |
| EP2216036A1 | Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control | Nestec S.A. | 09 |
| WO2010091991A1 | Lactobacillus helveticus cncm i-4095 and weight control | Arigoni et al. | 09 |
| US20100331641A1 | Devices for continual monitoring and introduction of gastrointestinal microbes | Gearbox LLC | 09 |
| US20160074505A1 | Method and System for Targeting the Microbiome to Promote Health and Treat Allergic and Inflammatory Diseases | Kovarik et al. | 09 |
| US20120058094A1 | Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota | New York University Dow Global Technologies LLC | 10 |
| US9040101B2 | Method to treat diabetes utilizing a gastrointestinal microbiome modulating composition | MicroBiome Therapeutics LLC | 11 |
| US20170348359A1 | Method and System for Treating Cancer and Other Age-Related Diseases by Extending the Health span of a Human | Kovarik et al. | 11 |
| US20170281091A1 | Capsule device and methodology for discovery of gut microbe roles in diseases with origin in gut | Lowell Zane Shuck | 12 |
| US20170372027A1 | Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions | uBiome Inc. | 14 |
| US20170286620A1 | Method and system for microbiome-derived diagnostics and therapeutics | uBiome Inc. | 14 |
| US20190030095A1 | Methods and compositions relating to microbial treatment and diagnosis of disorders | Whole Biome Inc. | 14 |
| WO2017216820A1 | Metagenomic method for in vitro diagnosis of gut dysbiosis | Putignani et al. | 16 |
| WO2017171563A1 | Beta-caseins and cognitive function | Clarke et al. | 16 |
| WO2017160711A1 | Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system | Strandwitz et al. | 17 |
| US20180318323A1 | Compositions and methods for improving gut health | Plexus Worldwide LLC | 17 |